menu
    • menu

    Company profile for Thryv Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Thryv Therapeutics Inc., previously called LQT Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. They have been pioneering a precision medicine approach to treat Long QT Syndrome via SGK1 inhibition since 2019 and have since evolved their portfolio to include the treatment of resistant and rare cancers. The development of SGK1 inhibitors represents a novel approach to target treatment-resistant ...
    Thryv Therapeutics Inc., previously called LQT Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. They have been pioneering a precision medicine approach to treat Long QT Syndrome via SGK1 inhibition since 2019 and have since evolved their portfolio to include the treatment of resistant and rare cancers. The development of SGK1 inhibitors represents a novel approach to target treatment-resistant cancers, and complement existing therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Thryv TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    999, boulevard De Maisonneuve Ouest , Suite 1250, Montréal, Québec H3A 3L4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://thryvtrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/thryv-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amy Rudolph Joins Thryv Board, Advancing Heart Failure Portfolio
    Amy Rudolph Joins Thryv Board, Advancing Heart Failure Portfolio

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amy-rudolph-phd-joins-thryv-therapeutics-board-of-directors-to-support-portfolio-progression-into-heart-failure-302620430.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Thryv Therapeutics To Present at 2025 Aha Scientific Sessions
    Thryv Therapeutics To Present at 2025 Aha Scientific Sessions

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thryv-therapeutics-to-present-at-the-2025-american-heart-association-scientific-sessions-in-new-orleans-la-302604646.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Thryv Therapeutics Joins 2025 Healthcare Investor Conference
    Thryv Therapeutics Joins 2025 Healthcare Investor Conference

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thryv-therapeutics-to-participate-in-upcoming-2025-healthcare-investor-conferences-302602619.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Thryv Therapeutics Clears IND for THRV-1268 in Long QT Syndrome
    Thryv Therapeutics Clears IND for THRV-1268 in Long QT Syndrome

    18 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thryv-therapeutics-announces-fda-ind-clearance-of-thrv-1268-for-long-qt-syndrome-302559593.html

    PR NEWSWIRE
    18 Sep 2025
    Share Share
    Thryv Therapeutics to Present at 2025 ESC Congress in Madrid
    Thryv Therapeutics to Present at 2025 ESC Congress in Madrid

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thryv-therapeutics-to-present-at-the-2025-european-society-of-cardiology-congress-in-madrid-spain-302537792.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share
    Thryv Therapeutics to Share Clinical Results, Join Investor Conf.
    Thryv Therapeutics to Share Clinical Results, Join Investor Conf.

    13 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thryv-therapeutics-to-share-recent-clinical-results-and-participate-in-upcoming-healthcare-investor-conferences-302453094.html

    PR NEWSWIRE
    13 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search